The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

A typical CGM detects glucose levels in the interstitial fluid with an enzyme-based sensor. The sensor converts glucose ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial ...

Welcome to the era of algorithm-driven diabetes management, where closed-loop glucose monitoring systems keep you from ...

Health Minister Jo Etienne Abela confirms the government will soon kick off the initiative to provide insulin pumps for Type ...

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus ...

An early-morning rise in blood sugar is common in people with diabetes. Find out more about why it happens and how to prevent ...

What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a ...

Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.

Reports Q4 revenue $8.3M, consensus $7.95M. “We took a giant step forward in diabetes care in 2024, delivering on our promise of One Year, One ...